Загрузка...
Evolving Therapeutic Strategies for the Classic Philadelphia-Negative Myeloproliferative Neoplasms
Despite the emergence of JAK inhibitors, there is a need for disease-modifying treatments for Philadelphia-negative myeloproliferative neoplasms (MPNs). JAK inhibitors ameliorate symptoms and address splenomegaly, but because of the heterogeneous contributors to the disease process, JAK inhibitor mo...
Сохранить в:
| Опубликовано в: : | EBioMedicine |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elsevier
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4739416/ https://ncbi.nlm.nih.gov/pubmed/26870834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2016.01.010 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|